MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 -0.54 (-22.98%)	---	---	---	-0.02 (-0.85%)	-0.52 (-22.48%)	0.9 (67.67%)	1.0 (75.19%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -20.1111
Diluted P/E:: -20.1111
RSI(14) 1m:: 15.14
VWAP:: 1.81
RVol:: 36.8264

Events

Period	Kind	Movement	Occurred At
60m	Price decrease 60m	2.6 -0.15 (-5.45%)	Oct 16 06:05
10m	Price decrease 10m	2.66 -0.09 (-3.27%)	Oct 16 06:04
1m	Price decrease 1m	2.66 -0.09 (-3.27%)	Oct 16 06:04
1m	Price decrease 1m	2.75 -0.06 (-2.14%)	Oct 16 06:01
1m	Price increase 1m	2.81 +0.06 (+2.18%)	Oct 16 06:00